Pfizer gains former Lilly oncology exec
Executive Summary
Pfizer taps Garry Nicholson to head its oncology franchise, the firm announces May 14. Nicholson, who served as Lilly's Executive Director of the U.S. Oncology Business Unit, will be senior VP and general manager of Pfizer's new Oncology Business Unit, which was established March 5 with plans to achieve double-digit growth globally for mature products (1"The Pink Sheet," March 10, 2008, p. 5)
You may also be interested in...
Pfizer Tasks “Established Products Unit” With Extending Life Of Mature Drugs
As Pfizer faces a future without several key blockbuster drugs, Lipitor among them, the company is setting out to extend the life of its mature franchises with the formation of a dedicated business unit for established brands
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.